title: The protein phosphatase inhibitor cantharidin induces head and foot formation in buds of Cassiopea andromeda (Rhizostomae, Scyphozoa).
abstract: The polyps of Cassiopea andromeda produce spindle shaped, freely swimming buds which do not develop a head (a mouth opening surrounded by tentacles) and a foot (a sticky plate at the opposite end) until settlement to a suited substrate. The buds, therewith, look very similar to the planula larvae produced in sexual reproduction. With respect to both, buds and planulae, several peptides and the phorbolester TPA have been found to induce the transformation into a polyp. Here it is shown that cantharidin, a serine/threonine protein phosphatase inhibitor, induces head and foot formation in buds very efficiently in a 30 min treatment, the shortest yet known efficient treatment. Some resultant polyps show malformations which indicate that a bud is ordinary polyp tissue in which preparatory steps of head and foot formation mutually block each other from proceeding. Various compounds related to the transfer of methyl groups have been shown to affect head and foot formation in larvae of the hydrozoon Hydractinia echinata. These compounds including methionine, homocysteine, trigonelline, nicotinic acid and cycloleucine are shown to also interfere with the initiation of the processes which finally lead to head and foot formation in buds of Cassiopea andromeda.
authors.affiliation: Zoological Institute, University, Köln, Germany.
authors.forename: N E
authors.initials: NE
authors.lastname: Kehls
authors.forename: K
authors.initials: K
authors.lastname: Herrmann
authors.forename: S
authors.initials: S
authors.lastname: Berking
mesh_terms: D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D002193:Cantharidin / Q000009:adverse effects / Q000494:pharmacology*; D003063:Cnidaria / Q000196:embryology* / Q000235:genetics*; D003515:Cycloleucine / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005121:Extremities / Q000196:embryology / Q000502:physiology; D006257:Head / Q000196:embryology / Q000502:physiology; D006710:Homocysteine / Q000494:pharmacology; D008715:Methionine / Q000494:pharmacology; D009525:Niacin / Q000494:pharmacology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors*; D012038:Regeneration; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors
chemical_list: D000470:Alkaloids; D004791:Enzyme Inhibitors; D006710:Homocysteine; D003515:Cycloleucine; D009525:Niacin; C009560:trigonelline; D008715:Methionine; D010749:Phosphoprotein Phosphatases; D002193:Cantharidin; D013755:Tetradecanoylphorbol Acetate